Idexx Laboratories (IDXX) Other Accumulated Expenses (2010 - 2018)

Idexx Laboratories has reported Other Accumulated Expenses for 9 years, with the latest figure at $65.8 million in Q1 2018.

• On a quarterly basis, Other Accumulated Expenses rose 18.53% year-over-year to $65.8 million in Q1 2018; TTM through Mar 2018 was $65.8 million, a 18.53% increase from a year earlier, with the FY2017 full-year figure at $64.4 million, down 10.49% from the prior year.
• Other Accumulated Expenses was $65.8 million for Q1 2018 at Idexx Laboratories, up from $64.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $72.0 million in Q4 2016, with the low at $44.6 million in Q1 2014.
• Average Other Accumulated Expenses over 5 years is $58.9 million, with a median of $60.2 million recorded in 2015.
• The sharpest annual moves came in 2015 and 2017: Other Accumulated Expenses soared 38.03% in 2015, then dropped 11.34% in 2017.
• Over 5 years, Other Accumulated Expenses stood at $55.7 million in 2014, then grew by 17.99% to $65.7 million in 2015, then rose by 9.62% to $72.0 million in 2016, then decreased by 10.49% to $64.4 million in 2017, then climbed by 2.18% to $65.8 million in 2018.
• The last three Other Accumulated Expenses figures came in at $65.8 million (Q1 2018), $64.4 million (Q4 2017), and $60.8 million (Q3 2017), per Business Quant data.